Qilu Pharma Announces Launch of a Generic Version of Vesicare® in the United States
ABOUT US
Qilu Pharma Announces Launch of a Generic Version of Vesicare® in the United States
Release time：
2019-05-20
May 20, 2019—Qilu Pharmaceutical today announced the U.S. approval and launch of Solifenacin Succinate Tablets, which makes the third Day 181 launched product for Qilu in US.
Up to now, Qilu has launched thirteen products in US and among them, ten products are the injectables.
Related News
0531-83126666 
wangzhan@qilu-pharma.com 
Tel: +86-531-83127705, 83127704, 83127706, 83127711
Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China
Email：export@qilu-pharma.com
监督举报
亲爱的合作伙伴：
欢迎举报以下行为！
索贿、暗箱操纵招标、内定中标单位、员工或亲属参与公司业务往来牟取私利、偷工减料、以次充好、故意刁难供应商等行为。
举报电话：0531-83126898/55820713/83126871
举报邮箱：qljc@qilu-pharma.com
收信地址：山东省济南市历城区旅游路8888号
齐鲁制药集团审计监察部
采购平台技术专线